Gene-Disorder Association · Article
Gene
ALKALK Receptor Tyrosine Kinase
×
First reported
2007
Supporting publications
13
Manually curatedApproved treatment annotated
Association Review
In brief
The association between ALK (ALK Receptor Tyrosine Kinase) and Lung Non-Small Cell Carcinoma is reported, with clinical genetic testing available.
Sources
1
Clinical variants
0
Symptoms
0
Compounds
24
Trials
1,973of 10,040 via ALK compounds
Publications
13
01
At a glance
Association overview
A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.
Request access
02
Provenance
Evidence and sources
1 source
Every contributing database and publication behind this association, with evidence type, strength, accessions and deep links.
Request access
3 source summaries
A gene summary alongside the source descriptions it was distilled from.
Request access
04
Lung Non-Small Cell Carcinoma
The disorder
6 database identifiers
The disorder’s summary, prevalence, aliases and cross-reference identifiers (OMIM, Orphanet, MONDO, ICD-10, MedGen).
Request access
05
Mechanism overlap
Shared mechanisms
1 shared pathway
Biological pathways and phenotype concepts shared by the gene and the disorder, with supporting publications.
Request access
06
Interventions
Therapeutics
24 compounds & drugs
Gene-targeting drugs and associated compounds, with class, approval status, mechanism, indications and trials.
Request access
07
Human studies
Clinical trials
10,040 clinical trials
Clinical trials reached through the pair’s compounds, keeping disorder-targeting trials separate from other indications.
Request access
13 publications
Publications linking the gene and the disorder, with title, authors, journal, year and citation metrics.
Request access
09
Provenance
References & sources
22 references
Every source and publication cited across this dossier, as one numbered reference list.
Request access